Annual Gross Profit
$523.74 M
-$56.27 M-9.70%
31 December 2023
Summary:
Supernus Pharmaceuticals annual gross profit is currently $523.74 million, with the most recent change of -$56.27 million (-9.70%) on 31 December 2023. During the last 3 years, it has risen by +$55.80 million (+11.93%). SUPN annual gross profit is now -9.70% below its all-time high of $580.02 million, reached on 31 December 2022.SUPN Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Gross Profit
$158.11 M
+$7.70 M+5.12%
30 September 2024
Summary:
Supernus Pharmaceuticals quarterly gross profit is currently $158.11 million, with the most recent change of +$7.70 million (+5.12%) on 30 September 2024. Over the past year, it has increased by +$23.83 million (+17.74%). SUPN quarterly gross profit is now at all-time high.SUPN Quarterly Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Gross Profit
$580.54 M
+$23.83 M+4.28%
30 September 2024
Summary:
Supernus Pharmaceuticals TTM gross profit is currently $580.54 million, with the most recent change of +$23.83 million (+4.28%) on 30 September 2024. Over the past year, it has increased by +$57.11 million (+10.91%). SUPN TTM gross profit is now at all-time high.SUPN TTM Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SUPN Gross Profit Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -9.7% | +17.7% | +10.9% |
| 3 y3 years | +11.9% | +21.3% | +19.0% |
| 5 y5 years | +33.1% | +62.5% | +48.3% |
SUPN Gross Profit High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -9.7% | +11.9% | at high | +38.1% | at high | +19.0% |
| 5 y | 5 years | -9.7% | +39.3% | at high | +74.1% | at high | +54.4% |
| alltime | all time | -9.7% | >+9999.0% | at high | >+9999.0% | at high | >+9999.0% |
Supernus Pharmaceuticals Gross Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $158.11 M(+5.1%) | $580.54 M(+4.3%) |
| June 2024 | - | $150.41 M(+18.1%) | $556.71 M(+6.9%) |
| Mar 2024 | - | $127.33 M(-12.0%) | $520.77 M(-0.6%) |
| Dec 2023 | $523.74 M(-9.7%) | $144.69 M(+7.8%) | $523.74 M(+0.1%) |
| Sept 2023 | - | $134.28 M(+17.3%) | $523.43 M(-3.2%) |
| June 2023 | - | $114.47 M(-12.2%) | $540.63 M(-6.1%) |
| Mar 2023 | - | $130.30 M(-9.7%) | $575.75 M(-0.7%) |
| Dec 2022 | $580.02 M(+14.9%) | $144.37 M(-4.7%) | $580.02 M(+0.4%) |
| Sept 2022 | - | $151.47 M(+1.3%) | $577.70 M(+3.8%) |
| June 2022 | - | $149.59 M(+11.2%) | $556.60 M(+6.4%) |
| Mar 2022 | - | $134.57 M(-5.3%) | $523.31 M(+3.7%) |
| Dec 2021 | $504.71 M(+7.9%) | $142.06 M(+9.0%) | $504.71 M(+3.5%) |
| Sept 2021 | - | $130.38 M(+12.1%) | $487.68 M(-0.7%) |
| June 2021 | - | $116.30 M(+0.3%) | $491.05 M(-0.4%) |
| Mar 2021 | - | $115.98 M(-7.2%) | $493.09 M(+5.4%) |
| Dec 2020 | $467.94 M(+24.4%) | $125.02 M(-6.5%) | $467.94 M(+6.5%) |
| Sept 2020 | - | $133.75 M(+13.0%) | $439.25 M(+9.0%) |
| June 2020 | - | $118.34 M(+30.3%) | $402.82 M(+4.6%) |
| Mar 2020 | - | $90.82 M(-5.7%) | $385.13 M(+2.4%) |
| Dec 2019 | $376.10 M(-4.4%) | $96.33 M(-1.0%) | $376.10 M(-3.9%) |
| Sept 2019 | - | $97.32 M(-3.3%) | $391.51 M(-0.4%) |
| June 2019 | - | $100.65 M(+23.1%) | $392.98 M(+1.2%) |
| Mar 2019 | - | $81.79 M(-26.8%) | $388.18 M(-1.4%) |
| Dec 2018 | $393.54 M | $111.75 M(+13.1%) | $393.54 M(+7.5%) |
| Sept 2018 | - | $98.79 M(+3.1%) | $366.07 M(+6.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2018 | - | $95.86 M(+10.0%) | $343.43 M(+7.5%) |
| Mar 2018 | - | $87.15 M(+3.4%) | $319.55 M(+11.3%) |
| Dec 2017 | $287.02 M(+41.4%) | $84.28 M(+10.7%) | $287.02 M(+9.8%) |
| Sept 2017 | - | $76.15 M(+5.8%) | $261.34 M(+9.5%) |
| June 2017 | - | $71.97 M(+31.7%) | $238.58 M(+10.7%) |
| Mar 2017 | - | $54.63 M(-6.8%) | $215.49 M(+6.1%) |
| Dec 2016 | $203.02 M(+46.0%) | $58.60 M(+9.8%) | $203.02 M(+9.6%) |
| Sept 2016 | - | $53.38 M(+9.2%) | $185.31 M(+9.6%) |
| June 2016 | - | $48.88 M(+15.9%) | $169.04 M(+9.7%) |
| Mar 2016 | - | $42.16 M(+3.1%) | $154.08 M(+10.8%) |
| Dec 2015 | $139.04 M(+60.0%) | $40.89 M(+10.2%) | $139.04 M(+9.4%) |
| Sept 2015 | - | $37.11 M(+9.4%) | $127.10 M(+14.1%) |
| June 2015 | - | $33.92 M(+25.1%) | $111.36 M(+5.6%) |
| Mar 2015 | - | $27.12 M(-6.3%) | $105.45 M(+21.3%) |
| Dec 2014 | $86.92 M(+696.3%) | $28.95 M(+35.5%) | $86.92 M(+29.3%) |
| Sept 2014 | - | $21.37 M(-23.7%) | $67.23 M(+42.8%) |
| June 2014 | - | $28.01 M(+226.2%) | $47.09 M(+143.3%) |
| Mar 2014 | - | $8.59 M(-7.3%) | $19.36 M(+77.3%) |
| Dec 2013 | $10.91 M(+637.5%) | $9.27 M(+657.2%) | $10.92 M(+562.4%) |
| Sept 2013 | - | $1.22 M(+341.9%) | $1.65 M(+288.7%) |
| June 2013 | - | $277.00 K(+88.4%) | $424.00 K(+188.4%) |
| Mar 2013 | - | $147.00 K(+250.0%) | $147.00 K(-81.7%) |
| Dec 2012 | $1.48 M(+84.3%) | - | - |
| Dec 2011 | $803.00 K | $42.00 K(+281.8%) | $803.00 K(+5.5%) |
| Sept 2011 | - | $11.00 K(-98.5%) | $761.00 K(+1.5%) |
| June 2011 | - | $750.00 K | $750.00 K |
FAQ
- What is Supernus Pharmaceuticals annual gross profit?
- What is the all time high annual gross profit for Supernus Pharmaceuticals?
- What is Supernus Pharmaceuticals annual gross profit year-on-year change?
- What is Supernus Pharmaceuticals quarterly gross profit?
- What is the all time high quarterly gross profit for Supernus Pharmaceuticals?
- What is Supernus Pharmaceuticals quarterly gross profit year-on-year change?
- What is Supernus Pharmaceuticals TTM gross profit?
- What is the all time high TTM gross profit for Supernus Pharmaceuticals?
- What is Supernus Pharmaceuticals TTM gross profit year-on-year change?
What is Supernus Pharmaceuticals annual gross profit?
The current annual gross profit of SUPN is $523.74 M
What is the all time high annual gross profit for Supernus Pharmaceuticals?
Supernus Pharmaceuticals all-time high annual gross profit is $580.02 M
What is Supernus Pharmaceuticals annual gross profit year-on-year change?
Over the past year, SUPN annual gross profit has changed by -$56.27 M (-9.70%)
What is Supernus Pharmaceuticals quarterly gross profit?
The current quarterly gross profit of SUPN is $158.11 M
What is the all time high quarterly gross profit for Supernus Pharmaceuticals?
Supernus Pharmaceuticals all-time high quarterly gross profit is $158.11 M
What is Supernus Pharmaceuticals quarterly gross profit year-on-year change?
Over the past year, SUPN quarterly gross profit has changed by +$23.83 M (+17.74%)
What is Supernus Pharmaceuticals TTM gross profit?
The current TTM gross profit of SUPN is $580.54 M
What is the all time high TTM gross profit for Supernus Pharmaceuticals?
Supernus Pharmaceuticals all-time high TTM gross profit is $580.54 M
What is Supernus Pharmaceuticals TTM gross profit year-on-year change?
Over the past year, SUPN TTM gross profit has changed by +$57.11 M (+10.91%)